Live and Let Die – Regulation of Villous Trophoblast Apoptosis in Normal and Abnormal Pregnancies

doi:10.1016/j.placenta.2008.07.003

Placenta

Volume 29, Issue 9, September 2008, Pages 772-783

https://doi.org/10.1016/j.placenta.2008.07.003 Get rights and content

Abstract

Since 1995 the number of publications investigating apoptosis in villous trophoblast has increased exponentially. This scientific interest is in part due to observations that this specialised form of cell death is increased in pregnancy complications such as pre-eclampsia and intra-uterine growth restriction. In addition, apoptosis is described in normal villous trophoblast and elements of the apoptotic machinery are involved in the fusion between cytotrophoblast and the overlying multinucleate syncytiotrophoblast. The increase in descriptions of apoptotic cell death in villous trophoblast has been accompanied by investigations of regulators of apoptosis. It is anticipated that understanding the regulation of apoptosis in villous trophoblast may provide new insights into placental pathologies. This review describes current knowledge regarding the expression and function of these regulators in villous trophoblast, both in normal and complicated pregnancies.

Introduction

Since Levy and Nelson reviewed the regulation of apoptosis in trophoblast in 2000 [1], the number of investigations regarding the control of apoptosis in the placenta and specifically villous trophoblast has increased exponentially (Fig. 1). This growth in interest has stemmed from two main avenues of investigation. Firstly, apoptosis is increased in villous trophoblast in pregnancies complicated by gestational trophoblast disease [2], [3], pre-eclampsia [4], [5] and intra-uterine growth restriction (IUGR) [6], [7], and secondly, apoptotic elements are associated with the fusion of cytotrophoblast and the overlying multinucleate syncytium [8]. As a consequence, regulators of apoptosis are now considered to have a major role in maintaining the integrity of villous trophoblast.

Section snippets

Cell turnover and programmed cell death

In mature tissue, undergoing proliferation, cells must die or be lost to maintain tissue homeostasis. Consequently, proliferation and programmed cell death are tightly regulated processes. The mammalian cell cycle is divided into distinct phases [9]. Quiescent (non-dividing) cells exist in the G₀ phase and enter the cell cycle at G₁. They pass through the S phase when DNA is replicated, progressing through the G₂ phase before entering mitosis (M-phase). Progression through each phase is

Apoptotic pathways

The similar appearance of apoptotic cells between species and tissues of an organism suggests a highly preserved control mechanism. Apoptosis may result from a pathway which is initiated from within the cell (intrinsic) or one which originates from an external signal (extrinsic). These are not distinct pathways and cross-activation occurs [18]. Both pathways culminate in the activation of aspartate-specific cysteine proteases, known as caspases, which digest intracellular proteins thereby

Regulation of apoptosis by intracellular proteins

The regulation of the intrinsic pathway of apoptosis is considered to have four component parts: (i) the recognition of cellular damage; (ii) altered transcription of downstream components of the apoptotic cascade; (iii) altered mitochondrial membrane permeability; and (iv) the modification of caspase activity. For ease of description these components may be regarded as temporally and spatially distinct. However, in reality there is overlap between these elements.

The recognition of cell damage

Placental apoptosis in normal and abnormal pregnancy

Terminal villi consist of an outer layer of trophoblast which encapsulates a matrix of connective tissue and blood vessels. This villous trophoblast layer consists of cytotrophoblast cells which proliferate, exit the cell cycle and then fuse to give rise to a multinucleate syncytiotrophoblast. Nuclei within the syncytiotrophoblast show signs of chromatin condensation and a proportion of nuclei aggregate in ‘syncytial knots’ [54] which may be lost into the maternal circulation [55], [56]. The

Extrinsic regulators

It is clear that villous trophoblast express many constituents of the extrinsic and intrinsic apoptotic pathways. The elements of the extrinsic pathway present in both cytotrophoblast and syncytiotrophoblast include: TNF receptors, Fas, Fas-ligand (Fas-L) and caspase-8 [76], [77], [78]. Some of these are altered in pre-eclampsia, but these proteins, particularly Fas/Fas-L, are considered equally important in mediating immune interactions and tolerance through the induction of immune cell

Apoptosis inhibitors

Trophoblast express many IAPs including: livin, survivin, human IAP-1 (HIAP-1), human IAP-2 (HIAP-2), NIAP and XIAP [107], [108], [109]. The majority of these are found in the syncytiotrophoblast cytoplasm. For example, XIAP is present in this location throughout pregnancy, although expression is stronger in the first trimester than the third [107] (Table 4). The majority of XIAP in the third trimester is thought to be an inactive 30 kDa isoform [110]. Survivin is also present in villous

Pro- and active caspases

Many caspases are present in villous trophoblast (Table 5), but due to its central role in cell digestion caspase-3 has been the subject of significant investigation. The presence of pro-caspase-3 has been described at the mRNA and protein level, localised to the cytotrophoblast [8], [101]. Active caspase-3 has been demonstrated by Western blotting, IHC and specific activity assay [77], [112], [113], [114]. In contrast to the expression of pro-caspase-3, active caspase-3 is only weakly

Dysregulation of regulators of apoptosis in villous trophoblast in placental pathology

There are a number of studies describing altered expression of the constituents of the intrinsic apoptotic pathway in conditions associated by aberrant trophoblast turnover. p53 expression is altered in GTD [87], [88], [104] and in accordance with this observation p53 is strongly expressed in choriocarcinoma-derived cell lines [83], [85], [97]. The expression of Mdm2 is increased in GTD, which may represent a downstream effect of p53 [87], [88]. Another downstream effect of p53 is evident in

The potential role of apoptosis in the development of placental pathology

The precise role of apoptosis in the development of placental pathology and clinical conditions such as pre-eclampsia and IUGR is yet to be determined. Undoubtedly, apoptosis in pre-eclampsia and IUGR will disrupt normal cytotrophoblast cell turnover in the villus, preventing the normal replenishment of mRNA for the syncytiotrophoblast, which may further decrease placental function, and may explain the relationship between these placental complications. There is evidence that stimulation of

Summary

To summarise, many factors capable of regulating apoptosis are present in villous trophoblast, even though their expression patterns change with pregnancy progression. In the third trimester, the syncytiotrophoblast is well protected against unwanted apoptosis, expressing Bcl-2, Mcl-1 and XIAP (Fig. 3). Owing to the low rate of cell proliferation of villous cytotrophoblasts in the third trimester, there is low expression of cell-cycle regulators such as p53 and p21. Prior to cytotrophoblast

References (137)

R. Levy et al.
To be, or not to be, that is the question. Apoptosis in human trophoblast
Placenta
(2000)
A.D. Allaire et al.
Placental apoptosis in preeclampsia
Obstet Gynecol
(2000)
D.N. Leung et al.
Increased placental apoptosis in pregnancies complicated by preeclampsia
Am J Obstet Gynecol
(2001)
R. Levy et al.
Trophoblast apoptosis from pregnancies complicated by fetal growth restriction is associated with enhanced p53 expression
Am J Obstet Gynecol
(2002)
E. Lees
Cyclin dependent kinase regulation
Curr Opin Cell Biol
(1995)
M.J. Arends et al.
Apoptosis: mechanisms and roles in pathology
Int Rev Exp Pathol
(1991)
A.L. Edinger et al.
Death by design: apoptosis, necrosis and autophagy
Curr Opin Cell Biol
(2004)
K. Kuida et al.
Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9
Cell
(1998)
M. Muzio et al.
FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death—inducing signaling complex
Cell
(1996)
E.A. Slee et al.
Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis
J Biol Chem
(2001)

X. Luo et al.

Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors

Cell

(1998)

H. Hsu et al.

The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation

Cell

(1995)

F.C. Kischkel et al.

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5

Immunity

(2000)

J. Yui et al.

Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts

Placenta

(1994)

M. Donovan et al.

Control of mitochondrial integrity by Bcl-2 family members and caspase-independent cell death

Biochim Biophys Acta

(2004)

S.P. Wheatley et al.

Survivin: a protein with dual roles in mitosis and apoptosis

Int Rev Cytol

(2005)

J. Davoodi et al.

Neuronal apoptosis-inhibitory protein does not interact with Smac and requires ATP to bind caspase-9

J Biol Chem

(2004)

A.M. Verhagen et al.

Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins

Cell

(2000)

C. Du et al.

Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition

Cell

(2000)

C.M. Sorenson

Bcl-2 family members and disease

Biochim Biophys Acta

(2004)

C.J. Jones et al.

Ultrastructure of the normal human placenta

Electron Microsc Rev

(1991)

M. Johansen et al.

Trophoblast deportation in human pregnancy—its relevance for pre-eclampsia

Placenta

(1999)

M. Kadyrov et al.

Expression of a cytokeratin 18 neo-epitope is a specific marker for trophoblast apoptosis in human placenta

Placenta

(2001)

S.C. Smith et al.

Placental apoptosis in normal human pregnancy

Am J Obstet Gynecol

(1997)

G.J. Burton et al.

A reappraisal of the contrasting morphological appearances of villous cytotrophoblast cells during early human pregnancy; evidence for both apoptosis and primary necrosis

Placenta

(2003)

C.J. Jones et al.

An ultrastructural and ultrahistochemical study of the human placenta in maternal pre-eclampsia

Placenta

(1980)

E. Jauniaux et al.

Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies

Am J Pathol

(2003)

A. Kale et al.

Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease

Am J Obstet Gynecol

(2001)

J. Hempstock et al.

The contribution of placental oxidative stress to early pregnancy failure

Hum Pathol

(2003)

N. Ishihara et al.

Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation

Am J Obstet Gynecol

(2002)

S.C. Smith et al.

Increased placental apoptosis in intrauterine growth restriction

Am J Obstet Gynecol

(1997)

V.S. Ratts et al.

Expression of BCL-2, BAX and BAK in the trophoblast layer of the term human placenta: a unique model of apoptosis within a syncytium

Placenta

(2000)

B. Tenney et al.

The placenta in toxaemia of pregnancy

Am J Obstet Gynecol

(1940)

A.E. Heazell et al.

Formation of syncytial knots is increased by hyperoxia, hypoxia and reactive oxygen species

Placenta

(2007)

I.P. Crocker et al.

Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction

Am J Pathol

(2003)

A. Kharfi et al.

Dissociation between increased apoptosis and expression of the tumor necrosis factor-alpha system in term placental villi with preeclampsia

Clin Biochem

(2006)

S. Pongcharoen et al.

Placental Fas and Fas ligand expression in normal early, term and molar pregnancy

Placenta

(2004)

M. Roncalli et al.

C-myc and tumour suppressor gene product expression in developing and term human trophoblast

Placenta

(1994)

A.E. Heazell et al.

Effects of oxygen on cell turnover and expression of regulators of apoptosis in human placental trophoblast

Placenta

(2008)

M. De Falco et al.

Expression and distribution of notch protein members in human placenta throughout pregnancy

Placenta

(2007)

L.P. Nampoothiri et al.

Proteomic profiling of forskolin-induced differentiated BeWo cells: an in-vitro model of cytotrophoblast differentiation

Reprod Biomed Online

(2007)

M. Olvera et al.

Immunohistochemical expression of cell cycle proteins E2F-1, Cdk-2, Cyclin E, p27(kip1), and Ki-67 in normal placenta and gestational trophoblastic disease

Mod Pathol

(2001)

A. Bamberger et al.

Expression patterns of the cell-cycle inhibitor p27 and the cell-cycle promoter cyclin E in the human placenta throughout gestation: implications for the control of proliferation

Placenta

(1999)

S.N. Bae et al.

Cytotoxic effect of zinc-citrate compound on choriocarcinoma cell lines

Placenta

(2007)

L. Danihel et al.

Expression of proliferation and apoptotic markers in human placenta during pregnancy

Acta Histochem

(2002)

S.Y. Wong et al.

Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression

Mod Pathol

(1999)

P.M. Chiu et al.

Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome: assessment by the caspase-related M30 CytoDeath antibody

Histopathology

(2001)

H. Endo et al.

Frequent apoptosis in placental villi from pregnancies complicated with intrauterine growth restriction and without maternal symptoms

Int J Mol Med

(2005)

B. Huppertz et al.

Apoptosis cascade progresses during turnover of human trophoblast: analysis of villous cytotrophoblast and syncytial fragments in vitro

Lab Invest

(1999)

K. Nasmyth

Viewpoint: putting the cell cycle in order

Science

(1996)

Cited by (92)

Quantitative chemoproteomics reveals O-GlcNAcylation of cystathionine γ-lyase (CSE) represses trophoblast syncytialization
2021, Cell Chemical Biology
Citation Excerpt :
This layer comprises the multinucleated syncytiotrophoblast (STB), which is formed through cell fusion of the mononucleated cytotrophoblasts (CTB), a process of syncytialization that is primarily induced by the activation of protein kinase A (PKA) and subsequently the upregulation of transcription factor glial cells missing-1 (GCM-1) and fusogenic protein Syncytin (Knerr et al., 2005). Pregnant disorders, such as preeclampsia (PE) and intrauterine growth restriction (IUGR) (Heazell and Crocker, 2008; Huppertz and Kingdom, 2004), are in tight association with compromised syncytialization. As the barrier of the mother and the fetus, STB is confronted with various physiological stimuli and may undergo active O-GlcNAcylation.
Emerging evidence indicates the involvement of O-GlcNAc modification in placental development and pregnant health through mechanisms that are not well understood. Herein, by applying the quantitative O-GlcNAc proteomics, we established a database of O-GlcNAcylated proteins in human placental trophoblasts. Hundreds of proteins that were dynamically O-GlcNAcylated during trophoblast differentiation were identified, among which cystathionine γ-lyase (CSE) exhibited the most significant change. Site-specific analysis by mass spectrometry revealed Ser¹³⁸ as the core O-GlcNAc site in CSE, and its O-GlcNAcylation promoted the enzymatic activity to produce H₂S, which in turn repressed trophoblast differentiation via inhibiting androgen receptor dimerization. Consistently, in preeclamptic placentas, remarkably enhanced CSE O-GlcNAcylation and H₂S production were associated with restricted trophoblast differentiation. The findings establish a resource of O-GlcNAc dynamics in human placenta, and provide a deeper insight into the biological significance of O-GlcNAcylation in placental development as well as potential therapeutic targets for the relevant pregnant complications.
Cell death mechanisms and their roles in pregnancy related disorders
2021, Advances in Protein Chemistry and Structural Biology
Autophagy and apoptosis are catabolic pathways essential for homeostasis. They play a crucial role for normal placental and fetal development. These cell death mechanisms are exaggerated in placental disorders such as preeclampsia, intrauterine growth restriction (IUGR) and gestational diabetes mellitus (GDM). Apoptosis is widely studied, highly controlled and regulated whereas; autophagy is an orderly degradation and recycling of the cellular components. Cellular senescence may be initiated by a variety of stimuli, including hypoxia, oxidative stress, reduction in survival signals and nutrition deprivation. Apoptosis is regulated by two types of pathways intrinsic and extrinsic. Extrinsic pathway is initiated by apoptosis inducing cells such as macrophages, natural killer cells whereas; intrinsic pathway is initiated in response to DNA damage, cell injury and lack of oxygen. In autophagy, the cell or organelles undergo lysosomal degradation. Placental apoptosis increases as the gestation progresses while autophagy plays a role in trophoblast differentiation and invasion. In pregnancy disorders like preeclampsia and IUGR, proapoptotic markers such as caspase 3, 8, BAX are higher and antiapoptotic markers like Bcl-2 are lower. In GDM, apoptotic markers are reduced resulting in increased placental mass and fetal macrosomia. Apoptosis in the pathological pregnancies is also influenced by the reduced levels of micronutrients and long chain polyunsaturated fatty acids resulting in disturbed placental biology. This chapter describes the role of various key molecular events involved in cellular senescence and the various factors influencing them. This will help identify future therapeutic strategies for better management of these processes.
Decreased placental apoptosis and autophagy in pregnancies complicated by gestational diabetes with large-for-gestational age fetuses
2020, Placenta
Dysregulation of placental apoptosis and autophagy are observed in pregnancy complications including preeclampsia and fetal growth restriction. However, studies of their changes in the placentas of women with gestational diabetes mellitus (GDM) show inconsistent results. We aimed to compare the changes in apoptosis, autophagy, and Bcl-2 family proteins in the placentas from women with normal pregnancies and those with GDM, with or without large-for-gestational age (LGA) infants and to investigate the effect of hyperglycemia on the changes in apoptosis, autophagy, and Bcl-2 family proteins in primary cytotrophoblastic cells.
Villous tissues were obtained from normal pregnant women and those with GDM, with or without LGA infants. Primary cytotrophoblast cells were isolated from normal term placentas and cultured under standard, hyperglycemic, or hyperosmotic conditions.
Compared to placentas from normal pregnant women, those from GDM women with LGA infants were heavier, had lower beclin-1 and DRAM levels, less M30 and cleaved PARP immunoreactivity, and increased Ki-67 immunoreactivity. These changes were associated with increased Bcl-xL and decreased Bak levels. Increased glucose concentration led to lower ATG5, beclin-1, LC3B-II, p62, and DRAM levels, lower annexin V and M30-positive cell percentages, and less cleaved PARP changes compared with standard culture conditions. Hyperglycemia caused higher Bcl-xL levels and lower Bak and Bad levels than did standard culture conditions.
There were differential changes in apoptosis and autophagy between placentas from normal pregnant women and those from GDM women with LGA infants. Bcl-2 family proteins are likely involved in the regulation of these changes.
Maternal overnutrition and mitochondrial function
2020, Molecular Nutrition: Mother and Infant
Pregnancy is a time of large physiological changes to maternal metabolism. Placental hormone secretions cause a rise in maternal insulin resistance that ensures adequate glucose supply to the developing fetus. Mitochondria in highly metabolically active organs—such as skeletal muscle, adipose tissue, pancreatic beta cells, and the placenta—play a critical role in accomplishing the metabolic alterations associated with healthy pregnancy. In mothers who are overweight or obese prior to falling pregnant, baseline insulin resistance is high, and is further exacerbated by the pregnancy-associated rise in insulin resistance. This, and other obesity-related metabolic maladaptations, has been linked to the development of important pregnancy disorders such as gestational diabetes mellitus and preeclampsia, which can have major adverse effects on the mother and offspring in both the short term and long term.
Time-restricted feeding reduces high-fat diet associated placental inflammation and limits adverse effects on fetal organ development
2019, Biochemical and Biophysical Research Communications
Citation Excerpt :
Both apoptosis and inflammation in placenta play an important role not only in placental physiology but also to the developing fetal tissues. Increase in apoptosis and pro-apoptotic proteins such as p53 have been implicated in some pregnancy-related complication like pre-eclampsia and intra-uterine growth restriction (IUGR) [40]. Therefore, the upregulation apoptotic signalling upon HFD-AL feeding may be involved in the observed placental dysfunction.
Maternal nutrition has become a major public health concern over recent years and is a known predictor of adverse long-term metabolic derangement in offspring. Time-restricted feeding (TRF), wherein food consumption is restricted to the metabolically active phase of the day, is a dietary approach that improves metabolic parameters when consuming a high-fat diet (HFD). Here, we tested whether TRF could reduce maternal HFD associated inflammation and thereby mitigate defects in fetal organ developmental. Female rats were kept on following three dietary regimens; Ad libitum normal chow diet (NCD-AL), Ad libitum HFD (HFD-AL) and Time-restricted fed HFD (HFD-TRF) from 5 months prior to mating and continued throughout pregnancy. Rat dams were sacrificed at embryonic day 18.5 (ED18.5) and placental tissues from these rats were processed for the analysis of cellular apoptosis, inflammatory cytokines (TNFα and IL-6), oxidative stress, endoplasmic reticulum (ER) stress and autophagy. Furthermore, fetal hepatic triglyceride (TG) content and fetal lung maturation were assessed at ED18.5. Biochemical analysis revealed that HFD-TRF rat had significantly lower serum TG levels and body weight compared to HFD-AL rats. Additionally, TRF significantly blocked HFD-induced placental apoptosis and inflammation via minimizing cellular stress, and restoring autophagic flux. In addition, fetal hepatosteatosis and delayed fetal lung maturation induced by HFD was significantly ameliorated in HFD-TRF compared to HFD-AL. Collectively, our results suggest that reducing placental inflammation via TRF could prevent adverse fetal metabolic outcomes in pregnancies complicated by maternal obesity.
Associations between fetal size, sex and both proliferation and apoptosis at the porcine feto-maternal interface
2018, Placenta
Citation Excerpt :
In response to cell stressors, tumour suppressor protein 53 (P53) is upregulated which initiates the intrinsic pathway. Apoptosis has been described in the human placenta where it is essential for trophoblast invasion, differentiation and survival [2–9]. Similarly, apoptosis and proliferation have been suggested to play a role in implantation in the pig [10–13].
Inadequate fetal growth has severe consequences for both neonatal and adult development. It is hypothesised that the feto-maternal interface associated with the lightest and male fetuses will undergo more apoptosis and less proliferation than those supplying the closest to mean litter weight (CTMLW) and female fetuses respectively.
Placental and endometrial samples associated with the lightest and CTMLW (gestational day (GD) 18 and 30), male and female (GD45, 60 and 90) Large White X Landrace conceptuses or fetuses were obtained. The mRNA expression of candidate genes involved in apoptosis or proliferation (BAX, BCL2, P53 and KI67) was quantified by qPCR. TUNEL staining was performed on placental samples supplying the lightest and CTMLW fetuses (GD45 and 60), of both sex (GD60).
Placentas associated with the lightest fetuses had decreased P53 and KI67 expression compared to the CTMLW fetuses at GD45. At GD60, P53 expression was increased in placentas supplying the lightest compared to CTMLW fetuses. P53 expression was increased in endometrial samples associated with the lightest compared to the CTMLW fetuses at GD45. At GD30 and GD60 respectively, BAX expression was increased and BCL2, P53 and KI67 expression were decreased in endometrial samples associated with females compared to their male littermates. TUNEL staining revealed no association between fetal size or sex, and apoptotic cell number.
This study has highlighted dynamic associations between fetal size, sex, and apoptosis and proliferation at the porcine feto-maternal interface. Further studies should be performed to improve the understanding of the mechanisms behind these findings.

View all citing articles on Scopus

View full text

Current OpinionLive and Let Die – Regulation of Villous Trophoblast Apoptosis in Normal and Abnormal Pregnancies

Abstract

Introduction

Section snippets

Cell turnover and programmed cell death

Apoptotic pathways

Regulation of apoptosis by intracellular proteins

Placental apoptosis in normal and abnormal pregnancy

Extrinsic regulators

Apoptosis inhibitors

Pro- and active caspases

Dysregulation of regulators of apoptosis in villous trophoblast in placental pathology

The potential role of apoptosis in the development of placental pathology

Summary

Placenta

Obstet Gynecol

Am J Obstet Gynecol

Am J Obstet Gynecol

Curr Opin Cell Biol

Int Rev Exp Pathol

Curr Opin Cell Biol

Cell

Cell

J Biol Chem

Cell

Cell

Immunity

Placenta

Biochim Biophys Acta

Int Rev Cytol

J Biol Chem

Cell

Cell

Biochim Biophys Acta

Electron Microsc Rev

Placenta

Placenta

Am J Obstet Gynecol

Placenta

Placenta

Am J Pathol

Am J Obstet Gynecol

Hum Pathol

Am J Obstet Gynecol

Am J Obstet Gynecol

Placenta

Am J Obstet Gynecol

Placenta

Am J Pathol

Clin Biochem

Placenta

Placenta

Placenta

Placenta

Reprod Biomed Online

Mod Pathol

Placenta

Placenta

Acta Histochem

Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression

Mod Pathol

Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome: assessment by the caspase-related M30 CytoDeath antibody

Histopathology

Frequent apoptosis in placental villi from pregnancies complicated with intrauterine growth restriction and without maternal symptoms

Int J Mol Med

Apoptosis cascade progresses during turnover of human trophoblast: analysis of villous cytotrophoblast and syncytial fragments in vitro

Lab Invest

Viewpoint: putting the cell cycle in order

Science

Current Opinion
Live and Let Die – Regulation of Villous Trophoblast Apoptosis in Normal and Abnormal Pregnancies